Dato-DXd is an ADC composed of a humanized trophoblast cell surface antigen 2 (TROP2)-directed monoclonal antibody covalently linked to DXd, a topoisomerase 1 inhibitor (TOP1i) payload, through a plasma-stable, tumor-selective, cleavable linker14. The gene discussed is TACSTD2; the disease is neoplasm.